Vancouver, British Columbia–(Newsfile Corp. – May 10, 2023) – Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) – Defence Therapeutics is a Canadian biotech company that develops immune-related cancer therapies with proprietary technology. With three clinical trials scheduled by year-end, the company offers growth potential for investors. Defence is seeking to license its technology to enhance other companies’ products in the pharmaceutical industry.
Cannot view this video? Visit:
https://www.b-tv.com/post/cse-dtc-investor-alert-defence-therapeutics-developing-immune-related-therapies-for-cancer-treatment-btv-30sec
Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF)
https://defencetherapeutics.com/
About BTV:
BTV-Business Television is Canada’s longest running business show. With Hosts Taylor Thoen and Jessica Katrichak, BTV features emerging companies across the country to bring viewers investment opportunities. BTV also produces News Alerts and branding/ awareness spots for issuers broadcast on BNN Bloomberg, Fox Business News, Bloomberg TV US and Bloomberg Terminals. www.b-tv.com
BTV – Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/165568
RADNOR, Pa.--(BUSINESS WIRE)--#classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors…
SAN JOSE, Calif., March 7, 2025 /PRNewswire/ -- Spectra7 Microsystems Inc. (TSXV: SEV) (OTCQB: SPVNF)…
Verified Market Research® is pleased to announce the release of its latest research report, "AI…
A roundup of the most newsworthy tech announcements from PR Newswire, including India's largest IT…
Prepare for the most challenging free-roam VR experience available. Dive into the intensity of Threat:…
Leading applied AI capabilities drove double-digit revenue growth for the Stagwell (STGW) firm in 2024…